Ecografía con contraste de segunda generación (SonoVue) en la valoración del tratamiento percutáneo del carcinoma hepatocelular. Comparación con la TC multifásica

Vilana, Ramón; Bianchi, Luis; Nicolau, Carlos; García, Montserrat; Squarcia, Mattia; Sánchez, Marcelo; Ayuso, Carmen; Ruscalleda, Neus; Sala, Margarita; Varela, Maria; Llovet, Josep Maria; Bruix, Jordi; Bru, Concepción.
Radiología (Madr., Ed. impr.) ; 47(2): 79-85, mar.-abr. 2005. ilus, tab
Artículo en Es | IBECS (España) | ID: ibc-036912

Documentos relacionados

  1. [Emphasis on targeted and immunotherapy for liver injury in hepatocellular carcinoma].
  2. [Efficacy analysis of hepatic arterial infusion chemotherapy combined with targeted and immune therapy followed by <sup>125</sup>I seeds implantation in the treatment of hepatocellular carcinoma with portal vain tumor thrombus].
  3. Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score.
  4. Prognostic value of combined pre- and postoperative albumin-to-alkaline phosphatase ratio for patients with hepatocellular carcinoma undergoing trans-catheter chemoembolisation.
  5. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
  6. [Exploring the Prognostic Features of Hepatocellular Carcinoma via Text Mining and Data Analysis].
  7. Artificial Intelligence and Precision Medicine: Outcome of Immunotherapy in Hepatocellular Carcinoma.
  8. Epigenetics in hepatocellular carcinoma.
  9. Gene therapy for people with hepatocellular carcinoma.
  10. [Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].